Publication Beamlines Strategic Pillar
Brandon Mansoor (2023). Radiologic biopsy system and method. Patent Number: US11737715B1.
Jason Chin; Nicolas HUGUENIN-DEZOT; Mohan MAHESH; Duy P. Nguyen; Shan Tang et al. (2025). Methods and Compositions. Patent Number: AU2025205622A1.
Edward Sargent; Cao-Thang DINH; Francisco PELAYO GARCIA DE ARQUER; Alexander IP (2019). Composite multilayered electrocatalysts for co2 reduction and associated methods. Patent Number: WO2019185622A1.
アニッシュ・スリ; Suri Anish; スティーブン・シェリフ; Sheriff Steven; スザンヌ・スシャード et al. (2017). Antibody polypeptide that antagonizes CD40. Patent Number: JP2017099391A.
Mark Anderson; Jieyi Wang; Archana Thakur; Debra Chao; Chung-Ming Hsieh et al. (2019). PROLAKTIN RECEPTOR BINDING PROTEINS AND THEIR USE. Patent Number: ME03075B.
Jafar Soltan; Nazanin Charchi Aghdam (2025). Method for the preparation of alkene oxides using ozone at room temperature. Patent Number: US20250179041A1.
ジェイソン チン; Chin Jason; デゾ ニコラス ユーグニン; Huguenin-Dezot Nicolas; モハン マヘシュ et al. (2025). Methods and Compositions. Patent Number: JP2025023942A.
Brandon Mansoor (2022). Radiologic biopsy system and method. Patent Number: US11457880B2.
Марк АНДЕРСОН; Цзеи ВАН; Арчана ТАКУР; Дебра ЧАО; Чунг-минг ХСИЕХ et al. (2018). PROTEINS CONNECTING THE PROLACTIN RECEPTOR AND THEIR APPLICATION. Patent Number: RU2018129572A.
Anish Suri; Steven Sheriff; Suzanne Suchard; Aaron Yamniuk; Stanley Krystek et al. (2013). Antibody polypeptides that antagonize cd40. Patent Number: CO6801649A2.
Trushar R. PATEL; Carla Stephanie COFFIN; Vanessa MEIER-STEPHENSON; Maulik D. BADMALIA (2021). Polypeptides directed against viral infection and uses thereof. Patent Number: CA3169031A1.
Zonghua Pu; Gaixia Zhang; Shuhui Sun (2023). Single-atom catalysts and method of manufacture thereof. Patent Number: CA3198525A1.
贾森·钦; 尼克拉·胡格囜-德佐; M·马赫什; 唐珊; D·P·阮 et al. (2025). Methods and compositions. Patent Number: CN113226375B.
Brandon Mansoor (2024). Radiologic biopsy system and method. Patent Number: US12133748B2.
(2021). Methods for improving response to anti-lif antibody treatment in individuals with cancer. Patent Number: IL279484A.